# A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease

> **NCT07307872** · — · COMPLETED · sponsor: **Amoneta Diagnostics SAS** · enrollment: 150 (actual)

## Conditions studied

- Alzheimer's Disease (AD)
- Neurodegenerative Disease
- Dementia
- Frontotemporal Dementia (FTD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07307872
- **Lead sponsor:** Amoneta Diagnostics SAS
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-23
- **Primary completion:** 2018-12-01
- **Final completion:** 2018-12-01
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2025-12-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07307872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07307872, "A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07307872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*